Zantac and its generic form of ranitidine have been voluntarily withdrawn from the market due to the presence of NDMA (N-nitrosodimethylamine), a possible carcinogen. The FDA is warning patients and healthcare providers about this recall while running additional tests to determine NDMA levels.
If you have used Zantac and have cancer, the lawyers are available to discuss your possible Zantac cancer lawsuit claims. Litigation is often the only way to hold pharmaceutical companies to account. Zantac lawyers will fight for fair compensation on your behalf. Call our office today for a free consultation.
Image Source: Google
Generic ranitidine, sold under the popular brand name Zantac, is one of the most extensively used antacids in the United States. Zantac, available by prescription or without a prescription, is a histamine-2 blocker that reduces the amount of acid in the patient's stomach. As an H2 blocker, it is often used as a medicine for heartburn associated with stomach acid digestion. Zantac is also approved for the cure of ulcers and gastroesophageal reflux disorder.
How was NDMA discovered in Zantac?
The EPA, FDA, and the WHO have classified NDMA as a carcinogen, and exposure to NDMA increases the risk of cancer. There are so many online pharmacies that found very high levels of NDMA, the active ingredient in Zantac, that increased cancer risk for those who were prescribed antacids or took them without a prescription.
Get a free consultation with Zantac lawyers:
Manufacturers of Zantac are currently awaiting lawsuits and separate lawsuits alleging that they intentionally concealed the risks and knowingly manufactured and sold ranitidine products containing possibly carcinogenic products to millions of people.